Cited by 376Bone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatments

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease

Open access

Greenblatt, Matthew B, Tsai, Joy N, Wein, Marc N·2017·Clinical Chemistry

DOI 10.1373/clinchem.2016.259085PMC PMC5549920

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Disorders of bone metabolism, most notably osteoporosis, are highly prevalent and predispose to fractures, causing high patient morbidity and mortality. Diagnosis and monitoring of bone metabolic defects can present a major challenge as these disorders are largely asymptomatic and radiographic measures of bone mass respond slowly to changes in bone physiology. CONTENT: Bone turnover markers (BTMs) are a series of protein or protein derivative biomarkers released during bone remodeling by osteoblasts or osteoclasts. BTMs can offer prognostic information on fracture risk that supplements radiographic measures of bone mass, but testing using BTMs has to take into account the large number of preanalytic factors and comorbid clinical conditions influencing BTM levels. BTMs respond rapidly to changes in bone physiology, therefore, they have utility in determining patient response to and compliance with therapies for osteoporosis. SUMMARY: BTMs are a useful adjunct for the diagnosis and therapeutic monitoring of bone metabolic disorders, but their use has to be tempered by the known limitations in their clinical utility and preanalytic variables complicating interpretation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1373/clinchem.2016.259085

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Matrix metalloproteinases and other matrix proteinases in relation to cariology: the era of dentin degradomics
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
MacLeod, A. M. (2009) · Kidney International · Cited by 2,216
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J., Lang, T., Garnero, P., Bouxsein, M., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,168
Foreword
Eckardt, K., & Kasiske, B. L. (2009) · Kidney International · doi:10.1038/ki.2009.188 · Cited by 1,168
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P., & Karsenty, G. (2010) · Cell · doi:10.1016/j.cell.2010.06.003 · Cited by 1,123
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Garnero, P., Sornay‐Rendu, E., Chapuy, M. C., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110307 · Cited by 1,000
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study
Hans, D. B., Goertzen, A. L., Krieg, M.-A., & Leslie, W. D. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.499 · Cited by 643
Endocrine Regulation of Male Fertility by the Skeleton
Oury, F., Sumara, G., Sumara, O., Ferron, M., Chang, H., Smith, C. E., Hermo, L., Suarez, S., Roth, B. L., Ducy, P., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.004 · Cited by 628
Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate
Eastell, R., Barton, I. P., Hannon, R., Chines, A. A., Garnero, P., & Delmas, P. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1051 · Cited by 585
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors
Brown, J. E., Cook, R. J., Major, P. P., Lipton, A., Fred Saad, C., Smith, M. R., Lee, K., Zheng, M., Hei, Y., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
Tsai, J. N., Uihlein, A. V., Lee, H., Kumbhani, R., Siwila-Sackman, E., McKay, E. A., Burnett‐Bowie, S. M., Neer, R. M., & Leder, B. Z. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60856-9 · Cited by 500
Self-citation
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice
Harvey, N. C., Glüer, C.-C., Binkley, N., McCloskey, E. V., Brandi, M. L., Cooper, C. C., Kendler, D. L., Lamy, O., Laslop, A., Camargos, B. M., et al. (2015) · Bone · doi:10.1016/j.bone.2015.05.016 · Cited by 489
Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions
Oury, F., Khrimian, L., Denny, C. A., Gardin, A., Chamouni, A., Goeden, N., Huang, Y.-Y., Lee, H., Srinivas, P., Gao, X.-B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.042 · Cited by 484
The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation
Garnero, P., Ferreras, M., Karsdal, M. A., NicAmhlaoibh, R., Risteli, J., Borel, O., Qvist, P., Delmas, P. D., Foged, N., & Delaissé, J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.859 · Cited by 472
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
Longworth, L., Yang, Y., Young, T. A., Mulhern, B. J., Alava, M. H., Mukuria, C., Rowen, D., Tosh, J. C., Tsuchiya, A., Evans, P., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18090 · Cited by 418
Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial
Bauer, D. C., Black, D. M., Garnero, P., Hochberg, M. C., Ott, S. M., Orloff, J. J., Thompson, D. E., Ewing, S. K., Delmas, P. D., & for the Fracture Intervention Trial Study Group (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040512 · Cited by 402
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study
Sornay‐Rendu, E., Munoz, F., Garnero, P., Duboeuf, F., & Delmas, P. D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050609 · Cited by 398
Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
Chesnut, C. H., McClung, M. R., Ensrud, K. E., Bell, N. H., Genant, H. K., Harris, S. T., Singer, F. R., Stock, J. L., Yood, R. A., Delmas, P. D., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80134-x · Cited by 361
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis
Cosman, F., Eriksen, E. F., Recknor, C. P., Miller, P. D., Guañabens, N., Kasperk, C. H., Papanastasiou, P., Readie, A., Rao, H., Gasser, J. A., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.238 · Cited by 358
Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting
Qvist, P., Christgau, S., Pedersen, B. J., Schlemmer, A., & Christiansen, C. (2002) · Bone · doi:10.1016/s8756-3282(02)00791-3 · Cited by 349
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
Henriksen, D. B., Alexandersen, P., Bjarnason, N. H., Vilsbøll, T., Hartmann, B., Henriksen, E. E., Byrjalsen, I., Krarup, T., Holst, J. J., & Christiansen, C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2180 · Cited by 331
Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis
Chen, P., Satterwhite, J. H., Licata, A. A., Lewiecki, E. M., Sipos, A. A., Misurski, D. A., & Wagman, R. B. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050105 · Cited by 309
Effect of feeding on bone turnover markers and its impact on biological variability of measurements
Clowes, J. A., Hannon, R. A., Yap, T. S., Hoyle, N. R., Blumsohn, A., & Eastell, R. (2002) · Bone · doi:10.1016/s8756-3282(02)00728-7 · Cited by 297
The effectiveness of collaborative care for people with memory problems in primary care: results of the CAREDEM case management modelling and feasibility study
Iliffe, S., Waugh, A., Poole, M., Bamford, C. H., Brittain, K., Chew-Graham, C. A., Fox, C., Katona, C., Livingston, G., Manthorpe, J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18520 · Cited by 285
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Leder, B. Z., Tsai, J. N., Uihlein, A. V., Burnett‐Bowie, S. M., Zhu, Y., Foley, K., Lee, H., & Neer, R. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4440 · Cited by 283
Self-citation
Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women
Gerdhem, P., Ivaska, K. K., Alatalo, S. L., Halleen, J. M., Hellman, J., Isaksson, A., Pettersson, K. S. I., Väänänen, H. K., Åkesson, K., & Obrant, K. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301244 · Cited by 283
Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9195-5 · Cited by 282
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
Lipton, A., Cook, R. J., Fred Saad, C., Major, P. P., Garnero, P., Terpos, E., Brown, J. E., & Coleman, R. E. (2008) · Cancer · doi:10.1002/cncr.23529 · Cited by 274
The Effect of Vitamin K Supplementation on Circulating Osteocalcin (Bone Gla Protein) and Urinary Calcium Excretion
Knapen, M. H. J., Hamulyák, K., & Vermeer, C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-1001 · Cited by 272
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
Eastell, R., Christiansen, C., Grauer, A., Kutílek, Š., Libanati, C. R., McClung, M. R., Reid, I. R., Resch, H., Siris, E. S., Uebelhart, D., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.251 · Cited by 261
Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
Klappacher, G., Franzen, P., Haab, D., Mehrabi, M. R., Binder, M., Plesch, K., Pacher, R., Grimm, M. F., Pribill, I., Eichler, H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80686-9 · Cited by 258
Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis
Bjarnason, N. H., Sarkar, S., Duong, T., Mitlak, B., Delmas, P. D., & Christiansen, C. (2001) · Osteoporosis International · doi:10.1007/s001980170020 · Cited by 227
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
Szulc, P., & Delmas, P. D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0660-9 · Cited by 218
Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk
Sarkar, S., Reginster, J., Crans, G. G., Díez‐Pérez, A., Pinette, K. V., & Delmas, P. D. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301243 · Cited by 210
Association of baseline levels of markers of bone and cartilage degradation with long‐term progression of joint damage in patients with early rheumatoid arthritis
Garnero, P., Landewé, R., Boers, M., Verhoeven, A. C., van der Linden, S., Christgau, S., van der Heijde, D. M. F. M., Boonen, A. E. R. C. H., & Geusens, P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10616 · Cited by 182
Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices
Woitge, H. W., Pecherstorfer, M., Li, Y., Keck, A. V., Horn, E., Ziegler, R., & Seibel, M. J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.5.792 · Cited by 181
Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies
Rosenquist, C., Qvist, P., Bjarnason, N. H., & Christiansen, C. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1439 · Cited by 177
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Glover, S. J., Eastell, R., McCloskey, E. V., Rogers, A., Garnero, P., Lowery, J., Belleli, R., Wright, T. M., & John, M. R. (2009) · Bone · doi:10.1016/j.bone.2009.07.091 · Cited by 177
Bone metabolism markers and bone mass in healthy pubertal boys and girls
van Coeverden, S. C. C. M., Netelenbos, J. C., de Ridder, C. M., Roos, J. C., Popp‐Snijders, C., & de Waal, H. A. D. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01573.x · Cited by 175
Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures
Bauer, D. C., Sklarin, P. M., Stone, K. L., Black, D. M., Nevitt, M. C., Ensrud, K. E., Arnaud, C. D., Genant, H. K., Garnero, P., Delmas, P. D., et al. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1404 · Cited by 170
Establishing a reference range for bone turnover markers in young, healthy women
Glover, S. J., Garnero, P., Naylor, K. E., Rogers, A., & Eastell, R. (2008) · Bone · doi:10.1016/j.bone.2007.12.218 · Cited by 149
Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity
Hirsh, V., Major, P. P., Lipton, A., Cook, R. J., Langer, C. J., Smith, M. R., Brown, J. E., & Coleman, R. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181651c0e · Cited by 149
Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
Delmas, P. D., Demiaux, B., Malaval, L., Chapuy, M. C., Edouard, C. M., & Meunier, P. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112400 · Cited by 147
Developmental appearance of the vitamin K-dependent protein of bone during calcification. Analysis of mineralizing tissues in human, calf, and rat.
Price, P. A., Lothringer, J. W., Baukol, S. A., & Reddi, A. H. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69522-0 · Cited by 140
Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
Bauer, D. C., Schwartz, A. V., Palermo, L., Cauley, J. A., Hochberg, M. C., Santora, A., Cummings, S. R., & Black, D. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1232 · Cited by 137
Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men
Finkelstein, J. S., Leder, B. Z., Burnett‐Bowie, S. M., Wyland, J. J., Lee, H., de la Paz, A. V., Gibson, K. L., & Neer, R. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0190 · Cited by 137
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
Chopin, F., Garnero, P., Hénanff, A. L., Debiais, F., Daragon, A., Roux, C., Sany, J., Wendling, D., Zarnitsky, C., Ravaud, P., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076604 · Cited by 136
High-resolution in vivo imaging of bone and joints: a window to microarchitecture
Geusens, P., Chapurlat, R. D., Schett, G. A., Ghasemzadeh, A., Seeman, E., de Jong, J. J. A., & van den Bergh, J. P. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.23 · Cited by 136
Biochemical markers of bone turnover in patients with metastatic bone disease
DEMERS, L. M., Costa, L., Chinchilli, V. M., Gaydos, L. J., Curley, E., & Lipton, A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1489 · Cited by 133
Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups
Burch, J., Rice, S., Yang, H., Neilson, A., Stirk, L., Francis, R., Holloway, P., Selby, P., & Craig, D. (2014) · Health Technology Assessment · doi:10.3310/hta18110 · Cited by 132
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
Jacques, R., Boonen, S., Cosman, F., Reid, I. R., Bauer, D. C., Black, D. M., & Eastell, R. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1644 · Cited by 129
Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study
Eastell, R., Nagase, S., Ohyama, M., Small, M., Sawyer, J. P. C., Boonen, S., Spector, T. D., Kuwayama, T., & Deacon, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.341 · Cited by 127
Changes in Bone Resorption Across the Menopause Transition: Effects of Reproductive Hormones, Body Size, and Ethnicity
Sowers, M. R., Zheng, H. T., Greendale, G. A., Neer, R. M., Cauley, J. A., Ellis, J. E., Johnson, S., & Finkelstein, J. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4113 · Cited by 126
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
Marotte, H., Pallot-Pradès, B., Grange, L., Gaudin, P., Alexandre, C., & Miossec, P. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2219 · Cited by 123
An ELISA-based method to quantify osteocalcin carboxylation in mice
Ferron, M., Wei, J., Yoshizawa, T., Ducy, P. F., & Karsenty, G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.008 · Cited by 120
Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.
Steinmann, B., Eyre, D. R., & Shao, P. (1995) · PubMed · Cited by 113
Consensus on the utility of bone markers in the malignant bone disease setting
Coleman, R. E., Costa, L., Fred Saad, C., Cook, R. J., Hadji, P., Terpos, E., Garnero, P., Brown, J. E., Body, J., Smith, M. R., et al. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.02.005 · Cited by 103
PTH—A Particularly Tricky Hormone
Garrett, G. L., Sardiwal, S., Lamb, E. J., & Goldsmith, D. J. A. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09580911 · Cited by 100
The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: A comparative review
Herrmann, M., & Seibel, M. J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.03.020 · Cited by 98
Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
Nofal, A. A., Altayar, O., Benkhadra, K., Agha, O. Q., Asi, N., Nabhan, M., Prokop, L. J., Tebben, P. J., & Murad, M. H. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3095-0 · Cited by 95
Paget’s disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling.
WHYTE, M. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.016 · Cited by 95
Biological Variability of Serum and Urinary N-Telopeptides of Type I Collagen in Postmenopausal Women
Eastell, R., Mallinak, N. J. S., Weiss, S., Ettinger, M. P., Pettinger, M. B., Cain, D. F., Flessland, K. A., & Chesnut, C. H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.594 · Cited by 94
PINP as an aid for monitoring patients treated with teriparatide
Tsujimoto, M., Chen, P., Miyauchi, A., Sowa, H., & Krege, J. H. (2010) · Bone · doi:10.1016/j.bone.2010.12.006 · Cited by 92
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
EUROFORS Study Group, Blumsohn, A., Marín, F., Nickélsen, T., Brixen, K., Sigurdsson, G. T., de la Vera, J. G., Boonen, S., Liu-Léage, S., Barker, C., et al. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1379-y · Cited by 80
Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products.
Garnero, P., Jouvenne, P., Buchs, N., Delmas, P. D., & Miossec, P. (1999) · Bone · doi:10.1016/s8756-3282(98)00193-8 · Cited by 79
Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical Analysis
Eastell, R., Hannon, R. A., Garnero, P., Campbell, M. J., & Delmas, P. D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.07090b · Cited by 76
Comparison of biochemical markers of bone turnover in paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links
Randall, A. G., Kent, G. N., Garcia‐Webb, P., Bhagat, C. I., Pearce, D. J., Gutteridge, D. H., Prince, R. L., Stewart, G. O., Stuckey, B. G. A., Will, R., et al. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110817 · Cited by 74
Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone
Apone, S., Lee, M. Y., & Eyre, D. R. (1997) · Bone · doi:10.1016/s8756-3282(97)00105-1 · Cited by 72
Chronic kidney disease and osteoporosis: evaluation and management
Miller, P. D. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.37 · Cited by 64
Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy
Jadon, D. R., Nightingale, A. L., McHugh, N. J., Lindsay, M. A., Korendowych, E., & Sengupta, R. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140223 · Cited by 59
BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate
McNabb, B., Vittinghoff, E., Schwartz, A. V., Eastell, R., Bauer, D. C., Ensrud, K. E., Rosenberg, E., Santora, A. C., Barrett-Connor, E. L., & Black, D. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1864 · Cited by 57
Urinary biochemical markers for bone resorption during the menstrual cycle
Gorai, I., Chaki, O., Nakayama, M., & MINAGUCHI, H. (1995) · Calcified Tissue International · doi:10.1007/bf00298428 · Cited by 53
Acid phosphatases as markers of bone metabolism
Igarashi, Y., Lee, M. Y., & Matsuzaki, S. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00431-2 · Cited by 52
Comparison of Serum and Urine Assays for Biochemical Markers of Bone Resorption in Postmenopausal Women with and without Hormone Replacement Therapy and in Men
FALL, P. M., Kennedy, D., Smith, J., Seibel, M. J., & Raisz, L. G. (2000) · Osteoporosis International · doi:10.1007/s001980070089 · Cited by 52
Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods
Kamel, S., Brazier, M., Neri, V., Picard, C., Samson, L., Desmet, G., & Jl, S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100916 · Cited by 51
Use of Bone Alkaline Phosphatase to Monitor Alendronate Therapy in Individual Postmenopausal Osteoporotic Women
Kress, B. C., Mizrahi, I. A., Armour, K. W., Marcus, R., Emkey, R. D., & Santora, A. C. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1009 · Cited by 51
Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation
Shieh, A., Han, W., Ishii, S., Greendale, G. A., Crandall, C. J., & Karlamangla, A. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4262 · Cited by 51
Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide
Koivula, M.-K., Ruotsalainen, V., Bjorkman, M. P., Nurmenniemi, S., Ikäheimo, R., Savolainen, K., Sorva, A. J., & Risteli, J. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009110 · Cited by 49
Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study.
Robinson-Cohen, C., Katz, R., Hoofnagle, A., Cauley, J., Furberg, C., Robbins, J., Chen, Z., Siscovick, D., de Boer, I. D., & Kestenbaum, B. (2011) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2010-2878 · Cited by 49
Sexual Differences in Bone Markers and Bone Mineral Density of Normal Chinese
Tsai, K., Pan, W., Hsu, S. H.-J., Cheng, W., Chen, C. K., Chieng, P., Yang, R., & TWu, S. (1996) · Calcified Tissue International · doi:10.1007/bf00369210 · Cited by 47
Associations between serum 25-hydroxyvitamin D and bone turnover markers in a population based sample of German children
Thiering, E., Brüske, I., Kratzsch, J., Hofbauer, L. C., Berdel, D., Berg, A. V., Lehmann, I., Hoffmann, B. H., Bauer, C.-P., Koletzko, S., et al. (2015) · Scientific Reports · doi:10.1038/srep18138 · Cited by 47
High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption
Kamel, S., Brazier, M., Desmet, G., Picard, C., Mennecier, I., & Sebert, J. (1992) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(92)80037-q · Cited by 46
The Tromsø Study: A Population-Based Study on the Variation in Bone Formation Markers with Age, Gender, Anthropometry and Season in both Men and Women
Midtby, M., Magnus, J. H., & Joakimsen, R. M. (2001) · Osteoporosis International · doi:10.1007/s001980170034 · Cited by 46
Collagen Markers Deoxypyridinoline and Hydroxylysine Glycosides: Pediatric Reference Data and Use for Growth Prediction in Growth Hormone-deficient Children
Rauch, F., Georg, M., Stabrey, A., Neu, C. M., Blum, W. F., Remer, T., Manz, F., & Schöenau, E. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.315 · Cited by 41
Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore, Y., Borderie, D., Lemaréchal, H., Cherruau, B., Ekindjian, O. G., & Kahan, A. (2003) · PubMed · Cited by 37
Multiple myeloma: changes in serum C‐terminal telopeptide of collagen type I and bone‐specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*
Lund, T., Abildgaard, N., Andersen, T. L., Delaissé, J., & Plesner, T. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01417.x · Cited by 37
Development of a Kinetic Assay for Band 5b Tartrate-resistant Acid Phosphatase Activity in Serum
Nakanishi, M., Yoh, K., Miura, T., 大橋, 建., Rai, S. K., & Uchida, K. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.4.469 · Cited by 36
Osteoid osteoma is an osteocalcinoma affecting glucose metabolism
Confavreux, C. B., Borel, O., Lee, F., Vaz, G., Guyard, M., Fadat, C., Carlier, M.-C., Chapurlat, R. D., & Karsenty, G. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1684-0 · Cited by 35
Serum Bone Turnover Markers in Patients with Primary Bone Tumors
Wang, J., Pei, F., Tu, C., Zhang, H., & Qiu, X. (2007) · Oncology · doi:10.1159/000113063 · Cited by 24
The Relationships Between the Degree of β-Isomerization of Type I Collagen Degradation Products in the Urine and Aging, Menopause and Osteoporosis with Fractures
Hoshino, H., Takahashi, M., KUSHIDA, K., Ohishi, T., & Inoue, T. (1999) · Osteoporosis International · doi:10.1007/s001980050164 · Cited by 24
Biochemical Markers of Bone Turnover in Osteoporosis
Szulc, P., & Bauer, D. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00067-4 · Cited by 22
Bone turnover in untreated polymyalgia rheumatica
Barnes, T. C. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh072 · Cited by 19
Transient Enhancement of Oxidant Stress and Collagen Turnover in Patients With Acute Worsening of Congestive Heart Failure
Kunishige, M., Kijima, Y., Sakai, T., Akutagawa, O., Matsuo, A., Nishibe, A., Nakagawa, Y., & Hata, T. (2007) · Circulation Journal · doi:10.1253/circj.71.1893 · Cited by 18
Serum Pyridinoline Levels and Prediction of Severity of Joint Destruction in Rheumatoid Arthritis
Krabben, A., Knevel, R., Huizinga, T. W. J., Cavet, G., & Mil, A. H. M. V. D. H. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121392 · Cited by 18
The direct effect of specific training and walking on bone metabolic markers in young adults with peak bone mass
Gombos, G., Bajsz, V., Sió, E., Tóth, V. S., Schmidt, B., Szekeres, L., & Kránicz, J. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.001 · Cited by 14

Flagged first, then by citations

Sorted by citations

Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Update on Osteoporosis Screening and Management
Anam, A. K., & Insogna, K. L. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.05.016 · Cited by 244
A systematic review and meta-analysis of bone loss in space travelers
Stavnichuk, M., Mikolajewicz, N., Corlett, T., Morris, M., & Komarova, S. V. (2020) · npj Microgravity · doi:10.1038/s41526-020-0103-2 · Cited by 217
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
Diet-Induced Low-Grade Metabolic Acidosis and Clinical Outcomes: A Review
Carnauba, R. A., Baptistella, A. B. D. P., Paschoal, V., & Hübscher, G. (2017) · Nutrients · doi:10.3390/nu9060538 · Cited by 147

See all 376

Authors: Greenblatt, M. B., Tsai, J. N., & Wein, M. N.
Affiliations: Weill Cornell Medicine (US)
Massachusetts General Hospital (US)
Corresponding author: Greenblatt, Matthew B
ORCID: Greenblatt, Matthew B
Tsai, Joy N
Wein, Marc N
Venue: Clinical Chemistry
Publisher: Oxford University Press (OUP)
Published: 2017-02-01
Volume: 63
Issue: 2
Pages: 464-474
ISSN: 0009-9147 (ISSN-L)
1530-8561
DOI: 10.1373/clinchem.2016.259085
PMC: PMC5549920
OpenAlex: W2560774896
Cited by: 376
References: 97
Citations by year: 2026: 24 · 2025: 50 · 2024: 54 · 2023: 60 · 2022: 54 · 2021: 49 · 2020: 39 · 2019: 23 · 2018: 16 · 2017: 6
FWCI: 2.39
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Clinical Chemistry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Career Award for Medical Scientists from the Burroughs Wellcome Fund
Office of the Director of the NIH (DP5OD021351)
Junior Investigator Award from the Musculoskeletal Transplant Foundation
NIAMS of the NIH (K23AR068447, K08AR067285)
Topics: Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords: bone turnover markers, metabolic bone disease, osteoporosis, fracture risk, bone remodeling, osteoblasts, osteoclasts, pre-analytical variables, treatment monitoring, biomarkers
MeSH terms: Bone and Bones, Bone Diseases, Metabolic, Humans, Biomarkers, Bone Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks